EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Global, regional, and national burdens: An overlapping meta-analysis on Staphylococcus aureus and its drug-resistant strains

Shuaibu Suleiman Adeiza, Md. Aminul Islam, Aminu Shittu

One Health Bulletin · 2024-12 · 4 (4) · 164-180

DOI: 10.4103/ohbl.ohbl_10_24 ↗
AbstractBibliografische Angaben

Abstract

Objective: To provide an inclusive blend of extant meta-analyses on the burden of Staphylococcus ( S. ) aureus and its resistant strains across diverse study populations, settings, and temporal contexts. Methods: The study has adopted PRISMA 2020-based guides and registered its protocol on Open Science Framework with an extensive literature search. Study quality was assessed by QUOROM and AMSTAR techniques. Data analysis included parsing of study-level statistical power, assessment of primary study overlap, pooling of meta-analysis results, subgroup and temporal analysis. Results: Totally 41 studies (64 meta-analyses) were selected by the inclusion criteria. The summary meta-analysis revealed global prevalence rates for S. aureus [24.8%, 95%C1 0.248(0.204-0.293), I2 = 93%], methicillin resistant S. aureus (MRSA) [5.8%, 95% CI 0.058(0.044-0.073), I2 = 92%], vancomycin intermediate S. aureus [1.7%, 95%C1 0.017(0.013–0.021), I2 = 36.4%], heterogeneous vancomycin intermediate S. aureus [5.2%, 95% CI 0.052(0.038–0.056), I2 = 36.4%], community-associated methicillin-resistant S. aureus [19.9%, 95%C1 0.199(-0.170–0.568), I2 = 96.67%), livestock-associated-MRSA [13.6%, 95% CI 0.136(-0.028–0.243), I2 = 97.7%], and mupirocin resistant S. aureus [7.6%, 95% CI 0.076(0.062–0.090), 12 = 0%]. Temporal analysis revealed that the burden community-associated methicillin-resistant S. aureus notably increased from 1.3% in 2003 to 39.0% in 2014. Coagulase-negative staphylococci rose from 23.2% in 2021 to 29.8% in 2022. Vancomycin resistant S. aureus peaked at 9.0% in 2018, declining to 2.6% in 2020. Livestock-associated-MRSA significantly increased to 19.0% in 2020. MRSA fluctuated, peaking at 52.7% in 2012 and 31.0% in 2022. Conclusions: The study reveals a considerable global prevalence of S. aureus at 24.8%. Regional differences were apparent, with Africa facing a high burden of MRSA at 40.8% of S. aureus and temporal trends exposed a dynamic state.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →